NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sinus PE Pressure plus Pain MAXIMUM STRENGTH | ACETAMINOPHEN, PHENYLEPHRINE HCL | CVS Pharmacy | a3b073b4-494c-4531-b08e-475c86ba321d | 2026-08-07 | Warnings | 362O9ITL9D |
| Severe Cold and Cough Nighttime | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE | WinCo Foods, LLC | dc56197c-c108-4b35-b791-dde5c3384ddd | 2026-08-07 | Warnings | 362O9ITL9D |
| Sinus Severe Non Drowsy, Daytime | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | 84c30ec9-a7b5-4d2f-95b2-d6fb895945de | 2026-08-07 | Warnings | 362O9ITL9D |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Salado Sales, Inc. | aef30709-f33d-48ff-b2d4-0639ffbd1ffd | 2026-08-07 | Warnings | M013 362O9ITL9D |
| Allergy Multi-Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HCL | ARMY AND AIR FORCE EXCHANGE SERVICE | f311b56f-b959-4070-9b23-82c642dd98b8 | 2026-08-06 | Warnings | 362O9ITL9D |
| Nalocet | OXYCODONE AND ACETAMINOPHEN | Forte Bio-Pharma LLC | f5f7dfca-a5c7-4445-8a5e-9ec62f33f5be | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| butalbital and acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Par Health | e619b656-4123-4878-b601-b0edad3c428b | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Aspirin | ASPIRIN | P & L Development, LLC | 4cd74cec-a209-4e92-b853-fbe5c95f7678 | 2026-08-06 | Warnings | M013 |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | PAI Holdings, LLC dba PAI Pharma | 95ac6875-6b14-4cde-8efb-80704e39b8d8 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen, Dextromethorphan HBr | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | NUVICARE LLC | 6713fdff-0e4e-4a9d-b218-34f786339c57 | 2026-08-06 | Warnings | 362O9ITL9D |
| Tension Headache Aspirin-Free | ACETAMINOPHEN, CAFFEINE | Rite Aid Corporation | 093a7c26-f2b1-4416-b193-81133d247d2e | 2026-08-06 | Warnings | M013 362O9ITL9D |
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | ARMY AND AIR FORCE EXCHANGE SERVICE | 8282cb5a-6c38-4500-93bb-461e4d65df1c | 2026-08-05 | Warnings | 362O9ITL9D |
| TOPCARE DAY TIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Topco Associates LLC | d1b89d17-b3b9-4133-88a3-8cd7c4efafa9 | 2026-08-05 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Kroger Company | bc17b2e5-4828-6a2e-e053-2995a90a8c63 | 2026-08-05 | Warnings | M013 362O9ITL9D |
| Infants TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 997b9551-c222-4a9c-8ba1-09a5f97495fa | 2026-08-05 | Warnings | M013 362O9ITL9D |
| ALKA SELTZER COLD Cold Flu and Congestion Fast Dissolve | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE | Bayer HealthCare LLC. | 507284c3-cad9-d65c-e063-6394a90a58a8 | 2026-08-05 | Warnings | 362O9ITL9D |
| Mantra Pain Gel raspberry | ACETAMINOPHEN | MOREMED INC. | 7c8bdf49-a6d2-4e42-b006-375f103fd0ac | 2026-08-05 | Warnings | M013 362O9ITL9D |
| Mantra Menstrual Pain Gel strawberry | ACETAMINOPHEN, PAMABROM | MOREMED INC. | 22291ca3-04c0-4386-8001-aa9bb45d7f3b | 2026-08-05 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | HARRIS TEETER | d2d2846d-4e0b-4d42-b300-60dd3b2cca1b | 2026-08-05 | Warnings | M013 313782 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | HARRIS TEETER | 960f5676-d8c5-470b-a663-4b8d152339b4 | 2026-08-05 | Warnings | M013 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.